1. “Augustine’s M Leap in Targeting Chronic Diseases” 2. “HDAC6...
Startup boasts pipeline of candidates targeting neuromuscular, neurodegenerative and cardio-metabolic diseases. Belgian biotech Augustine Therapeutics has raised $84.8 million in … Continue reading "Augustine Therapeutics lands $85m to advance HDAC6...